Revealing highly active specialties in sciences and social sciences LONDON, Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a…
Revealing highly active specialties in sciences and social sciences LONDON, Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a…
Revealing highly active specialties in sciences and social sciences LONDON, Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a…
November 25, 2024 08:00 ET | Source: Aphaia Pharma ZUG, Switzerland and SAN JUAN, Puerto Rico and TORONTO, Nov. 25,…
GREATER DES MOINES, Iowa, Nov. 20, 2024 /PRNewswire/ -- The Greater Des Moines Partnership has announced that its 2025 Annual…
GREATER DES MOINES, Iowa, Nov. 20, 2024 /PRNewswire/ -- The Greater Des Moines Partnership has announced that its 2025 Annual…
November 15, 2024 17:52 ET | Source: Protara Therapeutics NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq:…
Presentation to highlight advances in fibrostenotic Crohn’s Disease and the potential of localized PDE4 inhibition Carlsbad, CA, Nov. 14, 2024 (GLOBE…
November 12, 2024 16:30 ET | Source: Psyence Biomedical Ltd. NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical…
November 11, 2024 19:14 ET | Source: Pennant Group, Inc. EAGLE, Idaho, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The Pennant…